These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32171905)

  • 1. Relationship between norepinephrine dose, tachycardia and outcome in septic shock: A multicentre evaluation.
    Domizi R; Calcinaro S; Harris S; Beilstein C; Boerma C; Chiche JD; D'Egidio A; Damiani E; Donati A; Koetsier PM; Madden MP; McAuley DF; Morelli A; Pelaia P; Royer P; Shankar-Hari M; Wickboldt N; Zolfaghari P; Singer M
    J Crit Care; 2020 Jun; 57():185-190. PubMed ID: 32171905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality, Morbidity, and Costs After Implementation of a Vasopressin Guideline in Medical Intensive Care Patients With Septic Shock: An Interrupted Time Series Analysis.
    Bauer SR; Sacha GL; Reddy AJ
    Ann Pharmacother; 2020 Apr; 54(4):314-321. PubMed ID: 31679395
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of norepinephrine on the outcome of septic shock.
    Martin C; Viviand X; Leone M; Thirion X
    Crit Care Med; 2000 Aug; 28(8):2758-65. PubMed ID: 10966247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A time-sensitive analysis of the prognostic utility of vasopressor dose in septic shock.
    Chotalia M; Matthews T; Arunkumar S; Bangash MN; Parekh D; Patel JM
    Anaesthesia; 2021 Oct; 76(10):1358-1366. PubMed ID: 33687732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early prediction of norepinephrine dependency and refractory septic shock with a multimodal approach of vascular failure.
    Conrad M; Perez P; Thivilier C; Levy B
    J Crit Care; 2015 Aug; 30(4):739-43. PubMed ID: 25900257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.
    Russell JA; Lee T; Singer J; Boyd JH; Walley KR;
    Crit Care Med; 2017 Jun; 45(6):940-948. PubMed ID: 28333757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial.
    Permpikul C; Tongyoo S; Viarasilpa T; Trainarongsakul T; Chakorn T; Udompanturak S
    Am J Respir Crit Care Med; 2019 May; 199(9):1097-1105. PubMed ID: 30704260
    [No Abstract]   [Full Text] [Related]  

  • 9. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial.
    Liu ZM; Chen J; Kou Q; Lin Q; Huang X; Tang Z; Kang Y; Li K; Zhou L; Song Q; Sun T; Zhao L; Wang X; He X; Wang C; Wu B; Lin J; Yuan S; Gu Q; Qian K; Shi X; Feng Y; Lin A; He X; ; Guan XD
    Intensive Care Med; 2018 Nov; 44(11):1816-1825. PubMed ID: 29971593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock.
    Sacha GL; Lam SW; Duggal A; Torbic H; Reddy AJ; Bauer SR
    Pharmacotherapy; 2018 Mar; 38(3):319-326. PubMed ID: 29328496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory septic shock: efficacy and safety of very high doses of norepinephrine.
    Katsaragakis S; Kapralou A; Theodorou D; Markogiannakis H; Larentzakis A; Stamou KM; Drimousis P; Bramis I
    Methods Find Exp Clin Pharmacol; 2006 Jun; 28(5):307-13. PubMed ID: 16845448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the impact of obesity on safety and efficacy of weight-based norepinephrine dosing in septic shock: A single-center, retrospective study.
    Wong PJ; Pandya KA; Flannery AH
    Intensive Crit Care Nurs; 2017 Aug; 41():104-108. PubMed ID: 28343834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
    Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
    Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of duration of hypotension prior to norepinephrine initiation in medical intensive care unit patients with septic shock: A prospective observational study.
    Patel JJ; Kurman JS; Biesboer A; Taha H; Katz M; Szabo A; Simpson SQ; Jacobs ER
    J Crit Care; 2017 Aug; 40():178-183. PubMed ID: 28412642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical management for patients admitted to a critical care unit with severe sepsis or septic shock.
    Cheung WK; Chau LS; Mak II; Wong MY; Wong SL; Tiwari AF
    Intensive Crit Care Nurs; 2015 Dec; 31(6):359-65. PubMed ID: 26292920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early versus delayed administration of norepinephrine in patients with septic shock.
    Bai X; Yu W; Ji W; Lin Z; Tan S; Duan K; Dong Y; Xu L; Li N
    Crit Care; 2014 Oct; 18(5):532. PubMed ID: 25277635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
    Haan BJ; Cadiz ML; Natavio AM
    Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of Norepinephrine Weight-Based Dosing Compared With Non-Weight-Based Dosing in Achieving Time to Goal Mean Arterial Pressure in Obese Patients With Septic Shock.
    Vadiei N; Daley MJ; Murthy MS; Shuman CS
    Ann Pharmacother; 2017 Mar; 51(3):194-202. PubMed ID: 27886982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock.
    Wu JY; Stollings JL; Wheeler AP; Semler MW; Rice TW
    Ann Pharmacother; 2017 Jan; 51(1):13-20. PubMed ID: 27630192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Vasopressor Exposure and Mortality in Patients With Septic Shock.
    Roberts RJ; Miano TA; Hammond DA; Patel GP; Chen JT; Phillips KM; Lopez N; Kashani K; Qadir N; Cairns CB; Mathews K; Park P; Khan A; Gilmore JF; Brown ART; Tsuei B; Handzel M; Chang AL; Duggal A; Lanspa M; Herbert JT; Martinez A; Tonna J; Ammar MA; Nazer LH; Heavner M; Pender E; Chambers L; Kenes MT; Kaufman D; Downey A; Brown B; Chaykosky D; Wolff A; Smith M; Nault K; Gong MN; Sevransky JE; Lat I;
    Crit Care Med; 2020 Oct; 48(10):1445-1453. PubMed ID: 32706559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.